FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2907075655> ?p ?o ?g. }

• W2907075655 endingPage "120" @default.
• W2907075655 startingPage "109" @default.
• W2907075655 abstract "Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes Alfonso M Durán,1 Lorena M Salto,1 Justin Câmara,1 Anamika Basu,1 Ivette Paquien,1 W Lawrence Beeson,1,2 Anthony Firek,3 Zaida Cordero-MacIntyre,1,2 Marino De León1 1Center for Health Disparities and Molecular Medicine, Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA; 2Center for Nutrition, Healthy Lifestyle and Disease Prevention, School of Public Health, Loma Linda University, Loma Linda, CA, USA; 3Comparative Effectiveness and Clinical Outcomes Research Center, Riverside University Health System Medical Center, Moreno Valley, CA, USA Purpose: To determine whether dietary supplementation with omega-3 polyunsaturated fatty acids (PUFAs) reduces neuropathic pain symptoms in Mexican-Americans with type 2 diabetes.Methods: Forty volunteers with type 2 diabetes enrolled in the “En Balance-PLUS” program, which provided weekly nutrition–diabetes education and daily supplementation with 1,000 mg docosahexaenoic acid (DHA)–200 mg eicosapentaenoic acid over 3 months. The study assessed self-reported neuropathic pain symptoms pre/postintervention using the short-form McGill Pain Questionnaire (SF-MPQ), monitored clinical laboratory values at baseline and 3 months, and performed baseline and 3-month metabolomic analysis of plasma samples.Results: A total of 26 participants self-reported neuropathic pain symptoms at baseline. After 3 months of omega-3 PUFA supplementation, participants reported significant improvement in SF-MPQ scores (sensory, affective, and visual analogue scale; P<0.001, P=0.012, and P<0.001, respectively). Untargeted metabolomic analysis revealed that participants in the moderate–high SF-MPQ group had the highest relative plasma sphingosine levels at baseline compared to the low SF-MPQ group (P=0.0127) and the nonpain group (P=0.0444). Omega-3 PUFA supplementation increased plasma DHA and reduced plasma sphingosine levels in participants reporting neuropathic pain symptoms (P<0.001 and P<0.001, respectively). Increased plasma DHA levels significantly correlated with improved SF-MPQ sensory scores (r=0.425, P=0.030). Improved SF-MPQ scores, however, did not correlate with clinical/laboratory parameters.Conclusion: The data suggest that omega-3 PUFAs dietary supplementation may reduce neuropathic pain symptoms in individuals with type 2 diabetes and correlates with sphingosine levels in the plasma. Keywords: lipotoxicity, painful diabetic neuropathy, health disparities, community intervention, neuroprotection, Latinos" @default.
• W2907075655 created "2019-01-11" @default.
• W2907075655 creator A5022377766 @default.
• W2907075655 creator A5022663291 @default.
• W2907075655 creator A5026027305 @default.
• W2907075655 creator A5039814422 @default.
• W2907075655 creator A5051807984 @default.
• W2907075655 creator A5055244024 @default.
• W2907075655 creator A5055335279 @default.
• W2907075655 creator A5068343625 @default.
• W2907075655 creator A5081419036 @default.
• W2907075655 date "2019-01-01" @default.
• W2907075655 modified "2023-10-10" @default.
• W2907075655 title "Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes" @default.
• W2907075655 cites W1522387304 @default.
• W2907075655 cites W1588989558 @default.
• W2907075655 cites W1739691545 @default.
• W2907075655 cites W1814020593 @default.
• W2907075655 cites W1831581079 @default.
• W2907075655 cites W1943105996 @default.
• W2907075655 cites W1972095168 @default.
• W2907075655 cites W1976087089 @default.
• W2907075655 cites W1977887248 @default.
• W2907075655 cites W1978336088 @default.
• W2907075655 cites W1980508261 @default.
• W2907075655 cites W1982590077 @default.
• W2907075655 cites W1985425684 @default.
• W2907075655 cites W2000939065 @default.
• W2907075655 cites W2002864922 @default.
• W2907075655 cites W2003504000 @default.
• W2907075655 cites W2003540110 @default.
• W2907075655 cites W2004062365 @default.
• W2907075655 cites W2015157276 @default.
• W2907075655 cites W2032683573 @default.
• W2907075655 cites W2032798997 @default.
• W2907075655 cites W2049945223 @default.
• W2907075655 cites W2050389962 @default.
• W2907075655 cites W2051544795 @default.
• W2907075655 cites W2080072189 @default.
• W2907075655 cites W2082649626 @default.
• W2907075655 cites W2089181989 @default.
• W2907075655 cites W2090515056 @default.
• W2907075655 cites W2099366664 @default.
• W2907075655 cites W2100726346 @default.
• W2907075655 cites W2102138771 @default.
• W2907075655 cites W2103010344 @default.
• W2907075655 cites W2104754537 @default.
• W2907075655 cites W2133740866 @default.
• W2907075655 cites W2136749671 @default.
• W2907075655 cites W2140720733 @default.
• W2907075655 cites W2147802029 @default.
• W2907075655 cites W2151765510 @default.
• W2907075655 cites W2154536095 @default.
• W2907075655 cites W2157340973 @default.
• W2907075655 cites W2162465757 @default.
• W2907075655 cites W2162902338 @default.
• W2907075655 cites W2167740072 @default.
• W2907075655 cites W2176684800 @default.
• W2907075655 cites W2294158929 @default.
• W2907075655 cites W2550439821 @default.
• W2907075655 cites W2561727131 @default.
• W2907075655 cites W2579172691 @default.
• W2907075655 cites W2580480504 @default.
• W2907075655 cites W2597734448 @default.
• W2907075655 cites W2803664483 @default.
• W2907075655 cites W2891841682 @default.
• W2907075655 cites W2892648154 @default.
• W2907075655 doi "https://doi.org/10.2147/dmso.s187268" @default.
• W2907075655 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6329345" @default.
• W2907075655 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30662277" @default.
• W2907075655 hasPublicationYear "2019" @default.
• W2907075655 type Work @default.
• W2907075655 sameAs 2907075655 @default.
• W2907075655 citedByCount "18" @default.
• W2907075655 countsByYear W29070756552019 @default.
• W2907075655 countsByYear W29070756552020 @default.
• W2907075655 countsByYear W29070756552021 @default.
• W2907075655 countsByYear W29070756552022 @default.
• W2907075655 countsByYear W29070756552023 @default.
• W2907075655 crossrefType "journal-article" @default.
• W2907075655 hasAuthorship W2907075655A5022377766 @default.
• W2907075655 hasAuthorship W2907075655A5022663291 @default.
• W2907075655 hasAuthorship W2907075655A5026027305 @default.
• W2907075655 hasAuthorship W2907075655A5039814422 @default.
• W2907075655 hasAuthorship W2907075655A5051807984 @default.
• W2907075655 hasAuthorship W2907075655A5055244024 @default.
• W2907075655 hasAuthorship W2907075655A5055335279 @default.
• W2907075655 hasAuthorship W2907075655A5068343625 @default.
• W2907075655 hasAuthorship W2907075655A5081419036 @default.
• W2907075655 hasBestOaLocation W29070756551 @default.
• W2907075655 hasConcept C126322002 @default.
• W2907075655 hasConcept C134018914 @default.
• W2907075655 hasConcept C14184104 @default.
• W2907075655 hasConcept C1862650 @default.
• W2907075655 hasConcept C19038510 @default.
• W2907075655 hasConcept C2776091944 @default.
• W2907075655 hasConcept C2776432500 @default.
• W2907075655 hasConcept C2777107010 @default.

• next